Insider Transactions in Q4 2023 at Syros Pharmaceuticals, Inc. (SYRS)
Insider Transaction List (Q4 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 21
2023
|
Srinivas Akkaraju |
BUY
Open market or private purchase
|
Indirect |
904,977
+33.62%
|
$3,619,908
$4.42 P/Share
|
|
Dec 12
2023
|
David Roth Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
6,287
-100.0%
|
$25,148
$4.95 P/Share
|
|
Dec 06
2023
|
David Roth Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
6,287
-50.0%
|
$18,861
$3.95 P/Share
|
|
Nov 01
2023
|
Conley Chee President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,004
-32.73%
|
$12,008
$2.22 P/Share
|
|
Nov 01
2023
|
Kristin Stephens Chief Development Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,676
-26.44%
|
$11,352
$2.22 P/Share
|
|
Nov 01
2023
|
David Roth Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,301
-33.38%
|
$12,602
$2.22 P/Share
|
|
Nov 01
2023
|
Jason Haas Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,301
-31.11%
|
$12,602
$2.22 P/Share
|
|
Nov 01
2023
|
Nancy A Simonian |
SELL
Payment of exercise price or tax liability
|
Direct |
13,401
-11.8%
|
$26,802
$2.22 P/Share
|
|
Oct 31
2023
|
Conley Chee President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
17,000
+48.1%
|
-
|
|
Oct 31
2023
|
Kristin Stephens Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
17,000
+44.2%
|
-
|
|
Oct 31
2023
|
David Roth Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
18,875
+50.0%
|
-
|
|
Oct 31
2023
|
Jason Haas Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
18,875
+48.24%
|
-
|
|
Oct 31
2023
|
Nancy A Simonian |
BUY
Exercise of conversion of derivative security
|
Direct |
40,125
+26.11%
|
-
|
|
Oct 19
2023
|
Gerald E Quirk Chief Legal & Compliance Offic |
SELL
Payment of exercise price or tax liability
|
Direct |
6,897
-22.11%
|
$13,794
$2.1 P/Share
|
|
Oct 11
2023
|
Gerald E Quirk Chief Legal & Compliance Offic |
BUY
Exercise of conversion of derivative security
|
Direct |
22,500
+41.9%
|
-
|